Cited by 86Cytokine Signaling Pathways and InteractionsT-cell and B-cell ImmunologyIL-33, ST2, and ILC Pathways

Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer

Open access
Marković, Iva, Savvides, Savvas N.·2020·Frontiers in Immunology

Abstract

Thymic Stromal Lymphopoietin (TSLP) and Interleukin-7 (IL-7) are widely studied cytokines within distinct branches of immunology. On one hand, TSLP is crucially important for mediating type 2 immunity at barrier surfaces and has been linked to widespread allergic and inflammatory diseases of the airways, skin, and gut. On the other hand, IL-7 operates at the foundations of T-cell and innate lymphoid cell (ILC) development and homeostasis and has been associated with cancer. Yet, TSLP and IL-7 are united by key commonalities in their structure and the structural basis of the receptor assemblies they mediate to initiate cellular signaling, in particular their cross-utilization of IL-7Rα. As therapeutic targeting of TSLP and IL-7 via diverse approaches is reaching advanced stages and in light of the plethora of mechanistic and structural data on receptor signaling mediated by the two cytokines, the time is ripe to provide integrated views of such knowledge. Here, we first discuss the major pathophysiological roles of TSLP and IL-7 in autoimmune diseases, inflammation and cancer. Subsequently, we curate structural and mechanistic knowledge about receptor assemblies mediated by the two cytokines. Finally, we review therapeutic avenues targeting TSLP and IL-7 signaling. We envision that such integrated view of the mechanism, structure, and modulation of signaling assemblies mediated by TSLP and IL-7 will enhance and fine-tune the development of more effective and selective approaches to further interrogate the role of TSLP and IL-7 in physiology and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.01557

Cites

195 of 195 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Binding of IL-7 to the IL-7α receptor subunit leads to recruitment of the γc receptor, which forms a tripartite cytokine-receptor complex crucial to signalling cascades that lead to the development and homeostasis of T and B cells.

    “Binding of IL-7 to the IL-7α receptor subunit leads to recruitment of the γc receptor, which forms a tripartite cytokine–receptor complex crucial to signalling cascades that lead to the development and homeostasis of T and B cells29.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 196 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [161]ASP ASP 7266 - AdisInsight. (2020). Available online at: https://adisinsight.springer.com/drugs/800044779 (accessed March 5, 2020).

Cited by

Sorted by citations

Authors
Marković, I., & Savvides, S. N.
Affiliations
Ghent University (BE)
Corresponding author
Savvides, Savvas N.
Venue
Frontiers in Immunology
Published
2020-07-21
Volume
11
Pages
1557-1557
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3044670437
Cited by
86
References
196
Citations by year
2026: 7 · 2025: 22 · 2024: 12 · 2023: 22 · 2022: 12 · 2021: 10 · 2020: 1
FWCI
1.21
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fonds Wetenschappelijk Onderzoek (G0B4918N)
  • Vlaamse regering
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
thymic stromal lymphopoietin, IL-7, IL-7 receptor alpha, cytokine receptor signaling, Th2 immune response, allergic inflammation, autoimmune disease, cancer, T cell development, innate lymphoid cells
MeSH terms
Thymic Stromal Lymphopoietin, Animals, Autoimmune Diseases, Disease Susceptibility, Humans, Inflammation, Neoplasms, Structure-Activity Relationship, Genetic Variation, Signal Transduction, Interleukin-7, Cytokines, Receptors, Cytokine, Receptors, Interleukin-7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review